A blood test using infrared spectroscopy can be used to diagnose two types of cancer, lymphoma and melanoma, according to a study led by Georgia State University.
Researchers used mid-infrared spectroscopy to analyze blood serum derived from experimental mice and differentiate mice with non-Hodgkin’s lymphoma and subcutaneous melanoma from healthy mice and also between these two tumorous conditions. The mid-infrared spectral region of the electromagnetic spectrum is frequently used to characterize biological samples at the molecular level.
The findings, published in the journal Scientific Reports, suggest infrared spectroscopy can detect biochemical changes induced by non-Hodgkin’s lymphoma, a solid tumorous condition of the immune system, and subcutaneous melanoma, a deadly form of skin cancer, and has diagnostic potential as a screening technique for these cancers.
Studies have found the incidence rates of cutaneous melanoma have increased in many regions and populations over the last decade, specifically 3 to 7 percent per year among fair-skinned populations. Also, non-Hodgkin’s lymphoma accounts for 4.3 percent of new cancer cases in the United States. The available diagnostic regimen for both cancers, which includes tissue examination and biopsy, is time-consuming, invasive and costly, resulting in small compliance rates of eligible populations for cancer prescreening.
Developing a rapid and reliable prescreening strategy for melanoma and lymphoma is critical because early diagnosis and treatment of these malignancies improve the patients’ chances of survival. Fourier Transform Infrared (FTIR) spectroscopy in Attenuated Total Reflection (ATR) sampling mode provides high-quality results with better reproducibility compared to other vibrational spectroscopy. It has attracted scientists’ attention for its rapid and reliable detection of various health conditions using body fluid samples.
In previous work, Dr. Unil Perera, Regents’ Professor of Physics at Georgia State, and his colleagues discovered that a fast, simple blood test for ulcerative colitis using ATR-FTIR spectroscopy could provide a cheaper, less invasive alternative for screening compared to colonoscopy.
“Our final goal is to say we can use this infrared technique to identify various diseases,” Perera said. “This study shows infrared spectroscopy can identify cancer. Right now, when you go to the doctor, they do blood tests for sugar and several other things, but not for serious diseases like cancer and colitis. If you are a healthy person, there is a range that is normal. One day, we hope that even these serious diseases can be rapidly screened. Your primary doctor could keep a record of your number and check that every time you come back. Then, if there is some indication of cancer or colitis, they can do biopsies, colonoscopies, etc.”
In this recent study, the researchers used mice with lymphoma and melanoma cancers. Blood serum droplets extracted from cancerous mice and control mice were placed on an ATR crystal of the FTIR instrument. Incident infrared beams were absorbed and reflected by the serum, creating a wave that was recorded and used to produce an absorbance curve with peaks that identified the presence of certain biomarkers in the sample.
The researchers compared the absorbance curves from the control and tumorous mice and assessed biochemical changes induced by non-Hodgkin’s lymphoma and subcutaneous melanoma in the serum samples obtained from Dr. Yuan Liu’s research lab in Georgia State’s Department of Biology.
The study found remarkable differences between the ATR-FTIR spectra of serum samples from tumor-bearing mice with melanoma and non-Hodgkin’s lymphoma and healthy, control mice.
The findings are applicable to humans because mice and humans have some biomarkers and chemicals in common, Perera said. In previous studies on colitis, Perera and his colleagues identified specific chemicals that changed in humans and mice when colitis was present.
Using the data collected on the biomarkers for lymphoma and melanoma, the researchers can develop detectors for these particular absorbance peaks, which doctors could use to test patients’ blood samples for these cancers.
Doctors could track a patient’s blood test numbers starting in infancy and monitor them over the years to know exactly when the numbers begin to change. To make before and after comparisons of the blood samples, the data could be entered into a computer program and available statistical analysis software would determine any significant differences. Doctors wouldn’t need to do any sophisticated analysis, Perera said.
This work could lay the foundation for further research that could lead to the development of diagnostic techniques for the health care of melanoma and lymphoma cancer patients using body fluid samples that can be collected with relatively low risks, Perera said. In the future, Perera and his colleagues would like to use samples from human patients for infrared spectroscopy studies of cancer and other diseases.
The Latest on: Diagnosing diseases with infrared spectroscopy
- Global UV/Visible Spectroscopy Market Report 2020on November 30, 2020 at 5:45 am
The global UV/visible spectroscopy market is projected to reach USD 1.2 billion by 2025 from USD 1.0 billion in 2020 at a CAGR of 4.7%. Growth in UV/visible Spectroscopy market is mainly driven by ...
- T-ray technology reveals what's getting under your skinon November 26, 2020 at 5:34 am
A new method for analyzing the structure of skin using a type of radiation known as T-rays could help improve the diagnosis and treatment of skin conditions such as eczema, psoriasis and skin cancer.
- Can drinking cocoa make you smarter? Study suggests flavanol-rich drinks can increase people's mental agilityon November 24, 2020 at 9:20 pm
After consuming the flavanol-rich drink, participants had stronger and faster increase in blood oxygenation in the frontal cortex, a brain region that plays a key role in planning and decision-making ...
- Mid-IR Spectroscopy a Convenient, Accurate Means of Cancer Diagnosison November 13, 2020 at 12:45 pm
IR Spectroscopy (Prof. Dave Explains) Melanoma is a vicious form of skin cancers, and the current practice of diagnosis involves using a series of empirical (a dermoscopy) and invasive techniques ...
- Medical innovations that will revolutionize the future of your healthcare: Part 4on October 30, 2020 at 4:46 am
Handling tasks like collecting supplies, gathering soiled linens, and delivering fresh ones, Moxi could help to reduce health care professionals’ exposure to disease ... Total Reflection-Fourier ...
- Todos Medical receives notice of allowance from the European...on October 20, 2020 at 4:23 pm
The TBIA platform uses spectroscopy ... bowel disease, inherited syndrome, obesity, and smoking are some of the factors driving the in vitro CRC testing market. According to the American Cancer ...
- Psychology Todayon October 19, 2020 at 11:28 am
The experimenters utilized a novel neuroimaging technique, functional near-infrared spectroscopy (fNIRS), to uncover the live neural dynamics of face-to-face communication. The results of the ...
- Stroke Recovery Programon August 14, 2020 at 7:38 am
Her laboratory is dedicated to understanding the basic mechanisms by which neurons die in stroke and in neurodegenerative diseases, including Alzheimer ... He is also developing novel near-infrared ...
- Finding a needle in a haystackon June 5, 2019 at 4:34 am
Infrared (IR) spectroscopy is a powerful tool used by chemists to identify molecules and determine their structure. It could be used to analyse the proteins in biofluids such as blood serum, in order ...
- The Future of Breast Cancer Screeningon February 27, 2014 at 10:26 pm
Often, women at high risk of developing the disease turn to clinical trials ... Microwave imaging spectroscopy (MIS). This device uses microwave energy that is similar to cell phone frequencies ...
via Google News and Bing News